Cardiac biomarkers for detection of myocardial infarction: Perspectives from past to present

Clinical Chemistry

Volumn 50, Issue 11, 2004, Pages 2205-2213

  Rosalki, Sidney B ^a   Roberts, Robert ^b   Katus, Hugo A ^c   Giannitsis, Evangelos ^c   Ladenson, Jack H ^d   Apple, Fred S ^e  

^a 10 Wimpole News ^*  (United Kingdom)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYBUTYRATE DEHYDROGENASE; BIOLOGICAL MARKER; CREATINE KINASE MB; LACTATE DEHYDROGENASE; MYOSIN LIGHT CHAIN; TROPONIN I; TROPONIN T;

CORONARY ARTERY DISEASE; ELECTROPHORESIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; HUMAN TISSUE; RADIOIMMUNOASSAY; REVIEW; SPECTROPHOTOMETRY; ST SEGMENT ELEVATION; WESTERN BLOTTING;

BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MB FORM; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; ISOENZYMES; MYOCARDIAL INFARCTION; PORTRAITS; TROPONIN I; TROPONIN T;

EID: 7044233481     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.041749     Document Type: Review

References (62)

1. Rosalki SB, Wilkinson JH. Reduction of α-ketobutyrate by human serum. Nature 1960;188:1110-1.
2. Tanzer ML, Gilvarg C. Creatine and creatine measurement. J Biol Chem 1959;234:3201-4.
3. Kornberg A. Reversible enzymatic synthesis of diphosphopyridine nucleotide and inorganic pyrophosphate. J Biol Chem 1950;182:779-93.
4. Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 1967;69:696-705.
5. Rosalki SB. Enzyme assays in diseases of the heart and skeletal muscle. J Clin Pathol 1971;24(Suppl 4):60-70.
6. Collinson PO, Rosalki SB, Flather M, Wolman R, Evans T. Early diagnosis of myocardial infarction by timed sequential enzyme measurement. Ann Clin Biochem 1988;25:376-82.
7. Lang H. Creatine kinase isoenzymes. New York: Springer-Verlag, 1981:317pp.
8. Ebashi S, Toyokura Y, Momoi H, Sugita H. High creatine phosphokinase activity of sera of progressive muscular dystrophy. J Biochem 1959;46:103-6.
9. Dreyfus JC, Schapira G, Rasnais J, Scebat L. La creatine-kinase sérique dans le diagnostic de l'infarctus myocardique. Rev Fran Etud Clin Biol 1960;5:386-9.
10. van der Veen KJ, Willebrands AF. Isoenzymes of creatine phosphokinase in tissue extracts and in normal and pathological sera. Clin Chim Acta 1966;13:312-7.
11. Roberts R, Gowda KS, Ludbrook PA, Sobel BE. Specificity of elevated serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction. Am J Cardiol 1975;36:433-8.
12. Shell WE, Kjekshus JK, Sobel BE. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest 1971;50:2614-7.
13. Sobel BE, Shell WE. Serum enzyme determinations in the diagnosis and assessment of myocardial infarction. Circulation 1972;45:471-8.
14. Roberts R, Henry PD, Witteeveen SA, Sobel BE. Quantification of serum creatine phosphokinase isoenzyme activity. Am J Cardiol 1974;33:650-7.
15. Roberts R, Sobel BE, Parker CW. Radioimmunoassay for creatine kinase isoenzymes. Science 1976;194:855-7.
16. Roberts R. Isoenzyme analysis in the diagnosis of myocardial infarction. In Kones RJ, ed. New horizons in cardiovascular disease: basic science and diagnosis. Mount Kisco: Futura Publishing Company, Inc., 1980:67-107.
17. Vaidya HC, Maynard Y, Dietzler DN, Ladenson JH. Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme. Clin Chem 1986;32:657-62.
18. Wevers RA, Delsing M, Klein C, Gebbink JA, Soons JB. Post-synthetic changes in creatine kinase isozymes. Clin Chim Acta 1983;86:323-7.
19. George S, Ishikawa Y, Perryman MB, Roberts R. Purification and characterization of naturally occurring and in vitro induced multiple forms of MM creatine kinase. J Biol Chem 1984;259:2667-74.
20. Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler S, Hamburg RJ, et al. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1988;9:561-6.
21. Zimmerman J, From R, Meyer D, Boudreaux A, Wun CC, Smalling R, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1998;13:1671-7.
22. Ishikawa Y, Saffitz JE, Mealman TL, Grace AM, Roberts R. Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma. Clin Chem 1992;43:467-75.
23. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:987-92.
24. Schroeder JS, Lamb IH, Hu M. Do patients in whom myocardial infarction has been ruled out have a better prognosis after hospitalization than those surviving infarction? N Engl J Med 1980;303:1-5.
25. Madsen JK, Hansen JF. The prognosis for patients admitted to a coronary care unit due to suspected acute myocardial infarction with and without confirmed diagnosis. Acta Med Scand 1982;211:453-7.
26. Irvine RG, Cobb FR, Roe CR. Acute myocardial infarction and MB creatine phosphokinase. Relationship between onset of symptoms of infarction and appearance and disappearance of enzyme. Arch Intern Med 1980;140:329-34.
27. Lott JA, Stang JM. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin Chem 1980;26:1241-50.
28. Köhler G, Milstein C. Derivation of specific antibody producing tissue culture and tumor lines by cell fusion. Eur J Immunol 1976;6:511-9.
29. Leger JJ, Elzinga M. Studies on cardiac myosin light chains: comparison of the sequences of cardiac and skeletal myosin LC-2. Biochem Biophys Res Commun 1977;74:1390-6.
30. Sarkar S, Sreter FA, Gergely J. Light chains of myosin from white, red and cardiac muscles. Proc Natl Acad Sci U S A 1971;68:946-50.
31. Khaw BA, Gold HK, Fallon JT, Haber E. Detection of serum cardiac myosin light chains in acute experimental myocardial infarction. Circulation 1979;58:1130-6.
32. Khaw BA, Fallon J, Katus HA, Elmaleh D, Strauss H, Gold H, et al. Positron imaging of myocardial infarction with 68 Gallium DTPA anti myosin antibodies. Circulation 1979;59(Suppl II):135-40.
33. Katus HA, Diederich KW, Schwarz F, Uellner M, Scheffold T, Kubler W. Influence of reperfusion on serum concentrations of cytosolic creatine kinase and structural myosin light chains in acute myocardial infarction. Am J Cardiol 1987;60:440-5.
34. Katus HA, Diederich KW, Hoberg E, Kubler W. Circulating cardiac myosin light chains in patients with angina at rest: identification of a high risk subgroup. J Am Coll Cardiol 1988;11:487-93.
35. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-50.
36. Katus HA, Looser S, Hallermayer K, Remppis A, Scheffold T, Borgya A, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992;38:386-93.
37. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991;67:1360-7.
38. Katus HA, Schoeppenthau M, Tanzeem A, Bauer HG, Saggau W, Diederich KW, et al. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. Br Heart J 1991;65:259-64.
39. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991;83:902-12.
40. Katus HA, Remppis A, Looser S, Hallermeier K, Scheffold T, Kubler W. Enzyme linked immunoassay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 1989;21:1349-53.
41. Katus HA, Yasuda T, Gold HK, Leinbach RC, Strauss HW, Waksmonski C, et al. Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains. Am J Cardiol 1984;54:964-70.
42. Katus HA, Hurrell JG, Matsueda GR, Ehrlich P, Zurawski VR Jr, Khaw BA, et al. Increased specificity in human cardiac-myosin radioimmunoassay utilizing two monoclonal antibodies in a double sandwich assay. Mol Immunol 1982;19:451-5.
43. Muller-Bardorff M, Freitag H, Scheffold T, Remppis A, Kubler W, Katus HA. Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation 1995;92:2869-75.
44. Müller-Bardorff M, Hallermayer K, Schröder AA, Ebert C, Borgya A, Gerhardt W, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997;43:458-66.
45. Klein G, Kampmann M, Baum H, Scheffold T, Kubler W, Katus HA. Clinical performance of the new cardiac markers troponin T and CK-MB on the Elecsys 2010: a multicentre evaluation. Wien Klin Wochenschr 1998;3(Suppl):40-51.
46. Müller-Bardorff M, Rauscher T, Kampmann M, Schoolmann S, Laufenberg F, Mangold D, et al. Development and first evaluation of a device for quantitative bedside testing of cardiac troponin T. Clin Chem 1999;45:1002-8.
47. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). J Am Coll Cardiol 2000;36:970-1062.
48. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
49. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-5.
50. Giannitsis E, Muller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000;102:211-7.
51. Hamm CW, Giannitsis E, Katus HA. Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 2002;106:2871-2.
52. James S, Armstrong P, Califf R, Simoons ML, Venge P, Wallentin L, et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med 2003;115:178-84.
53. Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J 2003;146:446-52.
54. Apple FS, Johari V, Hoybook KJ, Weber-Shrikant E, Davis GK, Murakami MM. Operationalizing cardiac troponin I testing along ESC/ACC consensus guidelines for defining myocardial infarction: increasing rate of detection. Clin Chim Acta 2003;331:165-6.
55. Karmen A, Wróblewski F, LaDue JS. Transaminase activity in human blood. J Clin Invest 1954;126-33.
56. Bruns DE, Morgan WS, Davis JE, Ladenson JH. Low apparent creatine kinase activity and prolonged lag phases in serum of patients with metastatic disease: Elimination by treatment of sera with sulfhydryl agents. Clin Chem 1976;22:1889-95.
57. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature 1975;256:495-7.
58. Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987;113:1333-44.
59. Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992;38:2203-14.
60. Silva DP Jr, Landt Y, Porter SE, Ladenson JH. Development and application of monoclonal antibodies to human cardiac myoglobin in a rapid fluorescence immunoassay. Clin Chem 1991;37:1356-64.
61. Jaffe AS, Landt Y, Parvin CA, Abendschein DR, Geltman EM, Ladenson JH. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction. Clin Chem 1996;42:1770-6.
62. Hopkins PN, Williams RR. A survey of 246 suggested coronary risk factors. Atherosclerosis 1981;40:1-52.